_version_ 1785090561445724160
author Jahn, Ekaterina
Saadati, Maral
Fenaux, Pierre
Gobbi, Marco
Roboz, Gail
Bullinger, Lars
Lutsik, Pavlo
Riedel, Anna
Plass, Christoph
Jahn, Nikolaus
Walter, Claudia
Holzmann, Karlheinz
Hao, Yong
Naim, Sue
Schreck, Nicholas
Krzykalla, Julia
Benner, Axel
Keer, Harold
Azab, Mohammad
Döhner, Konstanze
Döhner, Hartmut
author_facet Jahn, Ekaterina
Saadati, Maral
Fenaux, Pierre
Gobbi, Marco
Roboz, Gail
Bullinger, Lars
Lutsik, Pavlo
Riedel, Anna
Plass, Christoph
Jahn, Nikolaus
Walter, Claudia
Holzmann, Karlheinz
Hao, Yong
Naim, Sue
Schreck, Nicholas
Krzykalla, Julia
Benner, Axel
Keer, Harold
Azab, Mohammad
Döhner, Konstanze
Döhner, Hartmut
author_sort Jahn, Ekaterina
collection PubMed
description
format Online
Article
Text
id pubmed-10428818
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288182023-08-17 P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY Jahn, Ekaterina Saadati, Maral Fenaux, Pierre Gobbi, Marco Roboz, Gail Bullinger, Lars Lutsik, Pavlo Riedel, Anna Plass, Christoph Jahn, Nikolaus Walter, Claudia Holzmann, Karlheinz Hao, Yong Naim, Sue Schreck, Nicholas Krzykalla, Julia Benner, Axel Keer, Harold Azab, Mohammad Döhner, Konstanze Döhner, Hartmut Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428818/ http://dx.doi.org/10.1097/01.HS9.0000968576.09006.a7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Jahn, Ekaterina
Saadati, Maral
Fenaux, Pierre
Gobbi, Marco
Roboz, Gail
Bullinger, Lars
Lutsik, Pavlo
Riedel, Anna
Plass, Christoph
Jahn, Nikolaus
Walter, Claudia
Holzmann, Karlheinz
Hao, Yong
Naim, Sue
Schreck, Nicholas
Krzykalla, Julia
Benner, Axel
Keer, Harold
Azab, Mohammad
Döhner, Konstanze
Döhner, Hartmut
P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title_full P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title_fullStr P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title_full_unstemmed P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title_short P417: GENOMIC LANDSCAPE AND PROGNOSIS IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY
title_sort p417: genomic landscape and prognosis in older acute myeloid leukemia patients not eligible for intensive chemotherapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428818/
http://dx.doi.org/10.1097/01.HS9.0000968576.09006.a7
work_keys_str_mv AT jahnekaterina p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT saadatimaral p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT fenauxpierre p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT gobbimarco p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT robozgail p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT bullingerlars p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT lutsikpavlo p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT riedelanna p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT plasschristoph p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT jahnnikolaus p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT walterclaudia p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT holzmannkarlheinz p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT haoyong p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT naimsue p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT schrecknicholas p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT krzykallajulia p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT benneraxel p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT keerharold p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT azabmohammad p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT dohnerkonstanze p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy
AT dohnerhartmut p417genomiclandscapeandprognosisinolderacutemyeloidleukemiapatientsnoteligibleforintensivechemotherapy